AndzonBio1
PrivateLast Round
Seed
Oct 29, 2024
Total Funding Raised
$3.28M
Company Overview
AndzonBio1 is a biotechnology company that operates as a thematic studio focused on translating breakthrough academic research into therapies for cardiovascular, renal, and metabolic (CVRM) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AndzonBio1 Comparables
Compare AndzonBio1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argobio | 87% | |
| European Biotech Venture Builder | 78% | |
| MedXCell SA | 78% |
For institutional investors. Book with your work email.
AndzonBio1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AndzonBio1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inserm Transfert | Seed |
| AdBio partners | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$3.28M raised from AdBio partners and Inserm Transfert.
For institutional investors. Book with your work email.
AndzonBio1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AndzonBio1's valuation, stock price, and market status.
Is AndzonBio1 a public or private company?
AndzonBio1 is a private company.
What is the current stock price of AndzonBio1?
AndzonBio1 is a private company, so its shares have no public market price. Caplight tracks AndzonBio1's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AndzonBio1 worth (valuation)?
Valuation information for AndzonBio1 is not publicly available.
Can I buy AndzonBio1 stock?
AndzonBio1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AndzonBio1's last funding round?
AndzonBio1's most recent funding round was Seed on October 29, 2024.
Who are the main investors in AndzonBio1?
Key investors in AndzonBio1 include Inserm Transfert, AdBio partners.
Will AndzonBio1 IPO soon?
No public IPO plans have been announced for AndzonBio1.
How can I track AndzonBio1 secondary market activity?
Caplight tracks bids, offers, and trades in AndzonBio1's shares on secondary markets.